To access this element change to forms mode OFF
Grant Award View - GA206715
Are nicotine replacement therapy and varenicline safe and effective for...
GA ID:
GA206715
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
20-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$904,422.30
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Are nicotine replacement therapy and varenicline safe and effective for women trying to quit smoking during pregnancy?
Purpose:
This project will measure the safety and effectiveness of two quit smoking medicines during pregnancy. It will use routinely collected data from Australia, New Zealand and the Nordic countries, for over 400,000 women who smoked during pregnancy. Women who used nicotine replacement therapy or varenicline during pregnancy will be compared to women who smoked but did not use these medicines in relation to quitting and adverse birth outcomes and neurodevelopmental problems among their children.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2010778
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, NEW ZEALAND, NORWAY